Andrew Goldsweig to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Andrew Goldsweig has written about Randomized Controlled Trials as Topic.
Connection Strength
1.962
-
Lingamsetty SSP, Doma M, Kritya M, Thyagaturu H, Ubaid M, Jitta SR, Prajapati K, Ramadan A, Al-Shammari AS, Martignoni FV, Seto A, Shlofmitz E, Basir MB, Megaly MS, Goldsweig AM. Mechanical outcomes of coronary stenting guided by intravascular ultrasound versus optical coherence tomography: A systematic review and meta-analysis with trial sequential analysis of randomized trials. Int J Cardiol. 2025 Sep 15; 435:133387.
Score: 0.713
-
Krishna MM, Joseph M, Ezenna C, Pereira V, Rossi R, Akman Z, Rubens M, Mahadevan VS, Nanna MG, Goldsweig AM. TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis. Cardiovasc Revasc Med. 2025 Oct; 79:78-89.
Score: 0.179
-
Ezenna C, Krishna MM, Joseph M, Ibrahim S, Pereira V, Jenil-Franco A, Nanna MG, Bangalore S, Goldsweig AM. Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials. Circ Cardiovasc Interv. 2025 May; 18(5):e015141.
Score: 0.177
-
Ezenna C, Krishna MM, Joseph M, Pereira V, Nadeem S, Valania G, Goldsweig AM. The Efficacy and Safety of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2025 Apr 15; 241:52-60.
Score: 0.175
-
Ezenna C, Krishna MM, Joseph M, Pereira V, Ramesh P, Ismayl M, Nanna MG, Goldsweig AM. Fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention in patients with myocardial infarction: A meta-analysis of randomized controlled trials. Cardiovasc Revasc Med. 2025 Sep; 78:31-40.
Score: 0.173
-
Mufarrih SH, Khan MS, Qureshi NQ, Akbar MS, Kazimuddin M, Goldsweig AM, Goodney PP, Aronow HD. An Endovascular- Versus a Surgery-First Revascularization Strategy for Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2024 Mar 01; 214:149-156.
Score: 0.163
-
Ismayl M, Machanahalli Balakrishna A, Aboeata A, Gupta T, Young MN, Altin SE, Aronow HD, Goldsweig AM. Meta-Analysis Comparing Catheter-Directed Thrombolysis Versus Systemic Anticoagulation Alone for Submassive Pulmonary Embolism. Am J Cardiol. 2022 09 01; 178:154-162.
Score: 0.146
-
Carson JL, Fergusson DA, Noveck H, Mallick R, Simon T, Rao SV, Cooper H, Stanworth SJ, Portela GT, Ducrocq G, Bertolet M, DeFilippis AP, Goldsweig AM, Kim S, Triulzi DJ, Menegus MA, Abbott JD, Lopes RD, Brooks MM, Alexander JH, H?bert PC, Goodman SG, Steg PG. Restrictive versus Liberal Transfusion in Myocardial Infarction - A Patient-Level Meta-Analysis. NEJM Evid. 2025 Feb; 4(2):EVIDoa2400223.
Score: 0.043
-
Franco AJ, Krishna MM, Joseph M, Ezenna C, Bakir ZE, Sudo RYU, Wippel CW, Ismayl M, Goldsweig AM, Uthirapathy I. Complete versus culprit-only percutaneous coronary intervention in elderly patients with acute coronary syndrome and multivessel coronary artery disease: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Jan; 70:1-9.
Score: 0.042
-
Machanahalli Balakrishna A, Ismayl M, Goldsweig AM, Peters LA, Alla VM, Velagapudi P, Zhao DX, Vallabhajosyula S. Intracoronary Imaging Versus Coronary Angiography Guidance for Implantation of Second and Third Generation Drug Eluting Stents in a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2023 09 01; 202:100-110.
Score: 0.039
-
Ismayl M, Abbasi MA, Al-Abcha A, El-Am E, Lundgren S, Goldsweig AM, Anavekar NS. Sodium-Glucose Cotransporter-2?Inhibitors in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Probl Cardiol. 2023 May; 48(5):101597.
Score: 0.038
-
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, H?bert PC. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023 03; 257:120-129.
Score: 0.038
-
Abusnina W, Baral N, Seri A, Ben-Dor I, Alkhouli M, Monteleone P, Haddad E, Goldsweig AM, Paul TK. Safety and Efficacy of Ultra Short-duration Dual Antiplatelet Therapy After Percutaneous Coronary Interventions: A Meta-analysis of Randomized Controlled Trials. Curr Probl Cardiol. 2022 Oct; 47(10):101295.
Score: 0.036